Company / Depreciation & Amortization
Immuneering Corp Depreciation & Amortization History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$247.2K
FY2023
5-year range
$24.3K / $247.2K
FY2021-FY2023
Trend
+443.7%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization changed +444% YoY in FY2023, a notable deviation from the 2-year average annual change of +265%.
Based on SEC 10-K filings.
$247,199 in FY2023.
Increased from $24,328 to $247,199 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, depreciation & amortization increased 443.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $247.2K | +443.7% |
| FY2022 | $45.5K | +86.9% |
| FY2021 | $24.3K | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026